MedTrace Logo

Effects of a Dietary Supplement on Lipoprotein Lipids and Inflammatory Markers

NCT03118583 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2018-05-15

No results posted yet for this study

Summary

The goal of this study is to assess the effects of a dietary supplement on fasting lipoprotein lipids and a marker of inflammation in men and women with levels of low-density lipoprotein cholesterol above desirable levels.

Conditions

  • Healthy Volunteers

Interventions

DIETARY_SUPPLEMENT

300 mg/day of dietary supplement containing carrageenan

300 mg/day of dietary supplement containing carrageenan.

Sponsors & Collaborators

  • Midwest Center for Metabolic and Cardiovascular Research

    lead OTHER

Principal Investigators

  • Kevin C Maki, PhD · MB Clinical Research and Consulting LLC

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-03-15
Primary Completion
2017-12-31
Completion
2018-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03118583 on ClinicalTrials.gov